Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
doxorubicin (Doxil) (1 trial)
Leukemia (Phase 1)
Lymphoma (Phase 1)
Trials (1 total)
Trial APIs (1 total)